130 related articles for article (PubMed ID: 12921861)
21. Divergent effects of anandamide transporter inhibitors with different target selectivity on social play behavior in adolescent rats.
Trezza V; Vanderschuren LJ
J Pharmacol Exp Ther; 2009 Jan; 328(1):343-50. PubMed ID: 18948500
[TBL] [Abstract][Full Text] [Related]
22. Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Costa B; Giagnoni G; Franke C; Trovato AE; Colleoni M
Br J Pharmacol; 2004 Sep; 143(2):247-50. PubMed ID: 15313881
[TBL] [Abstract][Full Text] [Related]
23. The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues.
Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
J Pharmacol Sci; 2005 May; 98(1):77-82. PubMed ID: 15888960
[TBL] [Abstract][Full Text] [Related]
24. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
Anikwue R; Huffman JW; Martin ZL; Welch SP
J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
26. Contractile response to a cannabimimetic eicosanoid, 2-arachidonoylglycerol, of longitudinal smooth muscle from the guinea-pig distal colon in vitro.
Kojima S; Sugiura T; Waku K; Kamikawa Y
Eur J Pharmacol; 2002 May; 444(3):203-7. PubMed ID: 12063081
[TBL] [Abstract][Full Text] [Related]
27. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
28. A GPR18-based signalling system regulates IOP in murine eye.
Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
[TBL] [Abstract][Full Text] [Related]
29. Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Shoemaker JL; Ruckle MB; Mayeux PR; Prather PL
J Pharmacol Exp Ther; 2005 Nov; 315(2):828-38. PubMed ID: 16081674
[TBL] [Abstract][Full Text] [Related]
30. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
Järbe TU; Liu Q; Makriyannis A
Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294
[TBL] [Abstract][Full Text] [Related]
31. Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat.
Beaulieu1 P; Bisogno1 T; Punwar S; Farquhar-Smith WP; Ambrosino G; Di Marzo V; Rice AS
Eur J Pharmacol; 2000 May; 396(2-3):85-92. PubMed ID: 10822060
[TBL] [Abstract][Full Text] [Related]
32. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
Franklin A; Parmentier-Batteur S; Walter L; Greenberg DA; Stella N
J Neurosci; 2003 Aug; 23(21):7767-75. PubMed ID: 12944505
[TBL] [Abstract][Full Text] [Related]
33. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
Fride E; Feigin C; Ponde DE; Breuer A; Hanus L; Arshavsky N; Mechoulam R
Eur J Pharmacol; 2004 Dec; 506(2):179-88. PubMed ID: 15588739
[TBL] [Abstract][Full Text] [Related]
34. The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes.
Oz M; Yang KH; Dinc M; Shippenberg TS
J Pharmacol Exp Ther; 2007 Nov; 323(2):547-54. PubMed ID: 17682128
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
36. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
Martín-Moreno AM; Reigada D; Ramírez BG; Mechoulam R; Innamorato N; Cuadrado A; de Ceballos ML
Mol Pharmacol; 2011 Jun; 79(6):964-73. PubMed ID: 21350020
[TBL] [Abstract][Full Text] [Related]
37. Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures.
Cardinal von Widdern J; Hohmann T; Dehghani F
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979350
[TBL] [Abstract][Full Text] [Related]
38. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
Vannacci A; Giannini L; Passani MB; Di Felice A; Pierpaoli S; Zagli G; Fantappiè O; Mazzanti R; Masini E; Mannaioni PF
J Pharmacol Exp Ther; 2004 Oct; 311(1):256-64. PubMed ID: 15187170
[TBL] [Abstract][Full Text] [Related]
39. Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity.
Massi P; Fuzio D; Viganò D; Sacerdote P; Parolaro D
Eur J Pharmacol; 2000 Jan; 387(3):343-7. PubMed ID: 10650181
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.
Fraga D; Raborn ES; Ferreira GA; Cabral GA
J Neuroimmune Pharmacol; 2011 Dec; 6(4):566-77. PubMed ID: 21735070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
